Cost-Effectiveness Analysis Of A Personalized Therapy For Genotype 1, Naive, Chronic Hepatitis C Patients In Italy

Personalized Therapy ◽

Genotype 1 ◽

Effectiveness Analysis ◽

PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS Setting

Value in Health ◽

10.1016/j.jval.2011.08.889 ◽

2011 ◽

Vol 14 (7) ◽

pp. A394-A395

Author(s):

J. Areias ◽

T. Branco ◽

F. Calinas ◽

A. Carvalho ◽

G. Macedo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Effectiveness Analysis ◽

Peginterferon Alfa ◽

Management of treatment-naïve chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options

Journal of Viral Hepatitis ◽

10.1111/jvh.12278 ◽

2014 ◽

Vol 22 (2) ◽

pp. 175-183 ◽

Cited By ~ 14

Author(s):

P. A. Cortesi ◽

A. Ciaccio ◽

M. Rota ◽

J. K. Lim ◽

S. De Salvia ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Treatment Options ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Treatment Naïve

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12871 ◽

2014 ◽

Vol 40 (6) ◽

pp. 657-675 ◽

Cited By ~ 50

Author(s):

S. Saab ◽

S. C. Gordon ◽

H. Park ◽

M. Sulkowski ◽

A. Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Ledipasvir / Sofosbuvir for The Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups

Value in Health ◽

10.1016/j.jval.2015.09.1966 ◽

2015 ◽

Vol 18 (7) ◽

pp. A585 ◽

Cited By ~ 2

Author(s):

J Félix ◽

J Almeida ◽

D Ferreira ◽

M Mota ◽

M Afonso-Silva ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Effectiveness Analysis

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Applied Health Economics and Health Policy ◽

10.1007/s40258-012-0007-8 ◽

2013 ◽

Vol 11 (1) ◽

pp. 65-78 ◽

Cited By ~ 28

Author(s):

Elamin H. Elbasha ◽

Jagpreet Chhatwal ◽

Shannon A. Ferrante ◽

Antoine C. El Khoury ◽

Pedro A. Laires

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.09.005 ◽

2020 ◽

Vol 21 ◽

pp. 164-171

Author(s):

Asrul Akmal Shafie ◽

Muhammad Radzi Abu Hassan ◽

Siew Chin Ong ◽

Suchin Virabhak ◽

Yuri Sanchez Gonzalez

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis

Digestive and Liver Disease ◽

10.1016/j.dld.2015.01.036 ◽

2015 ◽

Vol 47 ◽

pp. e15-e16 ◽

Cited By ~ 2

Author(s):

A. Ciaccio ◽

P.A. Cortesi ◽

G. Bellelli ◽

M. Rota ◽

S. Okolicsanyi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Oral Treatment ◽

Effectiveness Analysis ◽

Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China

Value in Health ◽

10.1016/j.jval.2018.04.1067 ◽

2018 ◽

Vol 21 ◽

pp. S154

Author(s):

W CHENG ◽

W Chen

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Effectiveness Analysis ◽

Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis

Journal of Viral Hepatitis ◽

10.1111/jvh.13419 ◽

2020 ◽

Cited By ~ 1

Author(s):

Jocelyn Chan ◽

John J. Kim ◽

Brett K. Barrett ◽

Abdullah Hamadeh ◽

Jordan J. Feld ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Decompensated Cirrhosis ◽

Effectiveness Analysis ◽

Cost-effectiveness analysis of glecaprevir/pibrentasvir regimen for treating Chinese patients with chronic hepatitis C genotype 1 and genotype 2 infection

Annals of Palliative Medicine ◽

10.21037/apm-21-863 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Hui-Jun Zhou ◽

Gang Wu ◽

Ji-Ming Li ◽

Nasheen Naidoo ◽

Yan-Xiang Xie ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Chinese Patients ◽

Genotype 1 ◽

Effectiveness Analysis ◽

Genotype 2